Illumina (ILMN) Research & Development (2009 - 2026)

Illumina (ILMN) has reported Research & Development for 18 consecutive years, with $252.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 2.02% year-over-year to $252.0 million; the trailing twelve-month figure through Jun 2026 stood at $960.0 million (down 4.76% YoY), and the FY2025 full-year result was $967.0 million, down 17.28% from the prior year.
• Research & Development advanced to $252.0 million in Q2 2026 per ILMN's latest filing, from $240.0 million in the prior quarter.
• Across five years, Research & Development topped out at $486.0 million in Q1 2023 and bottomed at $229.0 million in Q3 2025.
• Historically, Research & Development has averaged $302.7 million across 5 years, with a median of $319.0 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Research & Development soared 63.96% in 2022, then retreated 29.84% in 2023.
• Over 5 years, Research & Development stood at $325.0 million in 2022, then advanced by 4.92% to $341.0 million in 2023, then slipped by 24.93% to $256.0 million in 2024, then decreased by 6.64% to $239.0 million in 2025, then climbed by 5.44% to $252.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $252.0 million, $240.0 million, and $239.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.